MIS-C is a newly defined post-viral myocarditis and inflammatory vasculopathy of children
following COVID-19 infection. This review summarizes the literature on diagnosis …

Abstract Purpose of Review We highlight the new clinical entity multisystem inflammatory
syndrome in children (MIS-C), the progress in understanding its immunopathogenesis, and …

Abstract Purpose of Review In this article, I have reviewed current reports that explore
differences and similarities between multisystem inflammatory syndrome in children (MIS-C) …

Children and adolescents infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the …

Multisystem inflammatory syndrome in children (MIS-C) is a novel, life-threatening
hyperinflammatory condition that develops in children a few weeks after infection with …

The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection has been spreading worldwide since …

This study was conducted to assess the clinical spectrum, management, and outcome of
SARS-CoV-2-related multisystem inflammatory syndrome in children (MIS-C). We reviewed …

Abstract Purpose of Review To review the spectrum of cardiac manifestations and
treatments of multisystem inflammatory syndrome in children (MIS-C) associated with …

Background Multisystem inflammatory syndrome in children (MIS‐C) associated with
coronavirus disease 2019 has been increasingly recognized. However, the clinical features …

Abstract During the SARS-CoV-2-associated infection (COVID-19), pandemic initial reports
suggested relative sparing of children inversely related to their age. Children and neonates …